跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
维泰凯 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Larotrectinib Sulfate Capsules
Approved
化学药品
Larotrectinib Sulfate Capsules
BAYER AG
🇨🇳 National Medical Products Administration
Approval Date
Apr 8, 2022
Approval ID
8FWSEbmeGEN
Company
BAYER AG
Type
化学药品
Approval Details
Approval Id
8FWSEbmeGEN
Approval Number
国药准字HJ20220033
Generic Name
硫酸拉罗替尼胶囊
Generic Name En
Larotrectinib Sulfate Capsules
Trade Name
维泰凯
Drug Type
化学药品
Dosage Form
胶囊剂
Strength
100mg (按C₂₁H₂₂F₂N₆O₂计)
Reg Date
2022-04-08
Expired Date
2027-04-07
Company Name
BAYER AG
Production Company Name
PENN PHARMACEUTICAL SERVICES LIMITED
Company Detail Path
/organization/bayer-ag
Production Company Detail Path
/organization/penn-pharmaceutical-services-limited
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Apr 8, 2022
Approval ID
8FWSEbmeGEN
Type
化学药品
Back to NMPA Approvals